Biomarkers evaluating the tumor microenvironment, such as tumor PD-L1 expression, T-cell infiltration, cytokine signatures, and IDO expression have correlated with positive responses to immune checkpoint blockade [138]. The gene discussed is IDO1; the disease is neoplasm.